SEC Tracker
Get the app

Yarrow Bioscience YARW

Logos Global Management updates its stake in Yarrow Bioscience to 10.7%

Form
Schedule 13G/A
Filed
Importance
Routine

Not explained yet; the original is on EDGAR.

Ownership stake disclosure by Logos Global Management LP (amended)

View on EDGAR

Open in the app

Get an email when Yarrow Bioscience files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Rein Therapeutics RNTX public float $32M, Jun 30, 2025
  2. Insight Molecular Diagnostics IMDX public float $32M, Jun 30, 2025
  3. Kezar Life Sciences KZR public float $33M, Jun 30, 2025
  4. Provectus Biopharmaceuticals PVCT public float $31M, Jun 30, 2025
  5. Tempest Therapeutics TPST public float $30M, Jun 30, 2025